https://www.selleckchem.com/sc....reening/inhibitor-li
91 to -0.21; P=0.002). In the subgroup analyses, the abundance of F.prausnitzii was reduced in both active CD patients (SMD -0.78; 95% CI, -1.51 to -0.04; P=0.04) and active UC patients (SMD-0.44; 95%CI, -0.81 to -0.07; P=0.02) when compared with the patients with CD or UC in remission, respectively. A negative association between abundance of F.prausnitzii and IBD activity is observed, but a cut-off level of F.prausnitzii to diagnose and/or to start treating IBD is not determined. A negative association between abundance of